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ABSTRACT
Complementary to traditional gene mapping approaches used to
identify the hereditary components of complex diseases, integrative
genomics and systems genetics have emerged as powerful strategies
to decipher the key genetic drivers of molecular pathways that
underlie disease. Broadly speaking, integrative genomics aims to link
cellular-level traits (such as mRNA expression) to the genome to
identify their genetic determinants. With the characterization of
several cellular-level traits within the same system, the integrative
genomics approach evolved into a more comprehensive study
design, called systems genetics, which aims to unravel the complex
biological networks and pathways involved in disease, and in turn
map their genetic control points. The first fully integrated systems
genetics study was carried out in rats, and the results, which revealed
conserved trans-acting genetic regulation of a pro-inflammatory
network relevant to type 1 diabetes, were translated to humans.
Many studies using different organisms subsequently stemmed from
this example. The aim of this Review is to describe the most recent
advances in the fields of integrative genomics and systems genetics
applied in the rat, with a focus on studies of complex diseases ranging
from inflammatory to cardiometabolic disorders. We aim to provide
the genetics community with a comprehensive insight into how the
systems genetics approach came to life, starting from the first
integrative genomics strategies [such as expression quantitative trait
loci (eQTLs) mapping] and concluding with the most sophisticated
gene network-based analyses in multiple systems and disease
states. Although not limited to studies that have been directly
translated to humans, we will focus particularly on the successful
investigations in the rat that have led to primary discoveries of genes
and pathways relevant to human disease.
KEY WORDS: Integrative genomics, Systems genetics, eQTL, Gene
network, Rat
Introduction
Several gene mapping strategies such as genome-wide association
studies (GWAS; see Box 1 for a glossary of terms), whole-exome
sequencing (WES) and whole-genome sequencing (WGS) are now
widely applied to study the genetic etiology of complex diseases
(Altshuler et al., 2010). These approaches have led to the
identification of thousands of genes, genetic variants and
mutations that contribute to (or cause) human disease. However,
this yield of genetic susceptibility data has not been mirrored by
similar success in mapping the complex pathways and molecular
interactions that underlie pathogenic processes. Too often the
above-mentioned gene mapping strategies have been employed in
conjunction with a reductionist study design, which, for the most
part, is focused on the identification of single disease genes and
mutations, essentially through analysis of one gene at a time. From a
translational perspective, the identification of single genes (and
mutations) predisposing to disease is hardly informative of the best
point for therapeutic intervention, as this strategy ignores the
cellular context in which genes operate and the role of other
contributing factors (e.g. gene-by-environment interactions) in
human disease (Romanoski et al., 2010). Moreover, when applied to
human complex traits and disease, traditional genome-wide
mapping approaches face significant power limitations because
they require the assessment of large population samples – usually,
more than 1000 individuals to detect major effect mutations or
10,000 individuals to detect common disease-risk variants (Hong
and Park, 2012). Collecting data in large population samples is often
hampered by technical hurdles involved in human phenotyping, e.g.
difficulty of accurate monitoring of blood pressure in tens of
thousands of individuals and inadequate access to tissues for
analysis.
Despite the success of many gene mapping studies for several
human diseases, a major unresolved issue concerns how the
information encoded at the DNA level (e.g. genotypes) is translated
to complex phenotypes and disease. Specifically, once DNA
sequence variation is linked to whole-body phenotypes (Box 1) by
GWAS,WES orWGS approaches, the question remains as to which
molecular and signaling pathways are actually involved in the
disease process under investigation, and which of these should be
targeted to design new or better therapeutics. Therefore, genetic and
biomedical research is now moving towards a comprehensive
‘systems-level’ description of the molecular processes underlying
disease that goes beyond the identification of single genes and
disease-predisposing mutations. In this case, the overall aim is to
map pathogenic pathways, and to understand their regulation at the
genetic and epigenetic levels. This shift towards systems-level
analyses has been facilitated by the increasingly reduced costs and
ongoing improvements of high-throughput ‘omics’ technologies –
such as genomics, proteomics and metabolomics – which allow the
simultaneous examination of thousands of genes, proteins and
metabolites in a cost-effective way (Soon et al., 2013). The ‘omics’
revolution occurring in biology and biomedical research effectively
enables the study of genes, their gene products (e.g. mRNA,
proteins) and regulatory functions within multiple cell types and
systems, providing unprecedented opportunities to understand the
complex molecular basis of disease. Here, we start by delineating
the integrative genomics approach and then summarize the recent
progresses in systems genetics as an effective strategy to link
genotypes to complex phenotypes and elucidate underlying
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biological processes, with a focus on applications in the rat for the
study of complex disease.
From integrative genomics to systems genetics
One of the first strategies that emerged in the ‘omics’ era is
integrative genomics, which refers to the in silico integration of
different layers of ‘omics’ data, typically with the goal of
identifying genetic variants that control specific cellular-level
traits (such as DNA sequence variants regulating transcript
abundance; Box 1) (Giallourakis et al., 2005; Ware et al., 2012).
Systems genetics stemmed from this approach; however, it is a
more comprehensive integrative strategy than integrative
genomics. In contrast with integrative genomics, systems
genetics aims to identify the major (genetic) determinants of
disease and complex traits explicitly through the modeling and
analysis of biological networks (Fig. 1). In a typical systems
genetics study, DNA sequence variations are treated as the
naturally occurring source of ‘genetic perturbation’ of the
biological processes (represented as a biological network) that
play a role in the development of disease. The genetic perturbation
is sequentially linked to biological data, typically cellular-level
phenotypes (e.g. RNA and protein expression within biological
networks), and in turn associated with complex whole-body
phenotypes and disease (e.g. blood pressure or obesity). As such,
systems genetics goes beyond traditional integrative genomics by
leveraging so-called ‘systems biology’ strategies based on the
study of complex interactions within biological components
(which include molecules, cells, tissues or organisms) to identify
DNA variants together with biological molecular networks active
in disease (Civelek and Lusis, 2013). The integration of different
layers of ‘omics’ data also enables researchers to uncover the
specific molecular interactions (e.g. protein-protein interactions or
mRNA-mRNA co-expression) that are dysregulated in disease,
and ultimately can lead to the identification of functional targets
for therapeutic intervention (Rotival and Petretto, 2014; Yang
et al., 2015). A systems genetics study typically requires the
comprehensive molecular profiling (i.e. gene expression, protein
and metabolite levels) of tissues and access to cellular systems
relevant to disease pathogenesis using populations in which
natural genetic variability between individuals has also been
assessed. Although any population sample, family pedigree or
cross of laboratory animals can be considered, the advantages of
using segregating populations (Box 1) to link genetic variation to
cellular-level traits has been highlighted (Jansen and Nap, 2001).
DNA sequence variation is often assessed at the genome-wide
level using single nucleotide polymorphism (SNP) arrays, a
Box 1: Glossary
Cellular-level traits: quantitative traits measured at the level of the cell, usually assessed in homogeneous cell populations (e.g. an immortalized cell line)
or in a tissue sample.
Cis-eQTL: broadly speaking, this refers to local regulation of a gene. In humans, a gene is usually considered to be cis-regulated if there is a local genetic
variant controlling the expression level of the gene. However, the distance between the genetic variant and the regulated gene does depend on factors such
as genetic mapping resolution, linkage disequilibrium patterns, etc. In practice, a criteria used to define cis-eQTLs in humans is based on a cis window,
which is commonly defined as ±1 Mbp around the transcript start site (TSS) of the regulated gene (Lonsdale et al., 2013).
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas: a genome-editing tool that allows the targeted disruption or replacement of
the sequence of a gene(s) of choice.
Co-expression network: undirected network graph representing the co-expression relationships between sets of genes; this might be indicative of co-
regulated genes in a given cell type or tissue.
Comparative genomics: a strategy based on the comparison of genomic features across different organisms, commonly used to translate findings from the
rat (and other model organisms) to humans.
Copy number variation (CNV): a type of structural variant in which a DNA segment is present at a variable copy number in comparison with a reference
genome.
eQTL hotspot: a genomic locus that regulates the expression levels of a large number of genes located elsewhere.
GeneOntology (GO): defines concepts/classes used to describe gene function, and the relationships between these concepts. It classifies gene functions
along three aspects: molecular function (molecular activities of gene products), cellular component (biological material, where gene products are active)
and biological process (pathways and larger processes made up of the activities of multiple gene products).
Genome-wide association studies (GWAS): analysis of large sample cohorts to identify associations between common genetic variants and a disease
trait.
Master genetic regulator: a gene harboring sequence variants that control a gene co-expression network.
Principal component (PC) analysis: a variable reduction procedure aimed to develop a smaller number of artificial variables (called principal
components) that will account for most of the variance in the observed data. These principal components can then be used as ‘surrogate’ variables to
summarize the main patterns of variability in the data (where the first component extracted accounts for a maximal amount of total variance in the observed
variables).
Quantitative trait locus (QTL): a genomic locus that regulates a quantitative trait. Depending on the trait under genetic control, a QTL can be referred to as
eQTL (regulation of gene expression), mQTL (regulation of metabolite), methQTL (regulation of methylation), histoneQTL (regulation of histone
modification), miQTL (regulation of miRNA), pQTL (regulation of protein) or sQTL (regulation of splicing or relative transcripts abundances).
Segregating population: population with inter-individual genetic variability that can be generated by crossing two (or more) donor parents with different
genetic backgrounds. Genetic variants that segregate in the population can be assessed bymeans of several genotyping techniques, which enable study of
the co-segregation of genetic variants and phenotypic features in the population (Jansen, 2003).
Single nucleotide polymorphism (SNP): natural variation at the single nucleotide level in the DNA sequence, detected at the population level in a
particular species.
Trans-eQTL: refers to distal regulation of a gene. A gene is considered to be trans-regulated when its gene expression levels are influenced by a genetic
variant located further away from the physical location of the gene itself. In humans, a practical criteria that is frequently used to define a trans-eQTL is a
minimum distance of 1 Mbp between the genetic polymorphism and the transcript start site (TSS) of the regulated gene (Lonsdale et al., 2013).
Transcription activator-like effector nuclease (TALEN): a genome editing method that can be applied for the targeted disruption of one or more genes.
Whole-body trait/phenotype: any phenotype measured at the level of the whole organism, e.g. blood pressure, body mass index. This refers also to
disease traits, e.g. hyperglycemia, hypertension and cardiovascular disease.
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technology that allows the genotyping of millions of common
genetic variants per sample in a single experimental run
(LaFramboise, 2009) (Box 1).
Several high-throughput techniques are used to measure
molecular phenotypes and collect diverse ‘omics’ data. For
instance, transcriptomics data is currently collected by next-
generation sequencing (NGS) technologies such as RNA-
sequencing (RNA-seq) (Wang et al., 2009), whereas mass-
spectrometry and nuclear magnetic resonance (NMR) are often
the methodologies of choice for proteomic (Boersema et al., 2015)
and metabolomic (Fuhrer and Zamboni, 2015) data collection. As a
direct result of the development of these widely accessible high-
throughput techniques for molecular and phenotypic analyses,
integrative genomics and systems genetics studies have grown in
number and scope over the last decade. We queried the National
Center for Biotechnology Information (NCBI) literature database,
PubMed (http://www.ncbi.nlm.nih.gov/pubmed), to retrieve
‘integrative genomics’ and ‘systems genetics’ publications, and
our search highlighted the growing use of these strategies in
biomedical research in recent years (Fig. 2). Although humans are
the predominant ‘model organism’ of choice, the earliest systems
genetics studies (from 2007 and onwards) were primarily carried
out in rodents (particularly in mice; Fig. 2). Overall, several
different model organisms have been exploited for systems genetics
studies because of their lower complexity compared with humans,
ease of access to different cells and tissues, and reduced
dimensionality of the ‘omics’ data collected (e.g. smaller
genomes). These features facilitated the initial full-scale
application of the systems genetics approach to the study of
complex traits and human disease in model organisms.
Data modeling strategies used in system genetics
There are two key types of genome-wide data modeling strategies
that are used (and often integrated) in systems genetics studies:
quantitative trait locus (QTL; Box 1) mapping of cellular-level
traits, and gene regulatory network analysis. Each of these
approaches has been extensively used in isolation in integrative
genomics, for instance using expression QTL (eQTL) mapping
(see below). Before discussing the full-scale systems genetics
integration of these methods, we will give a brief overview of each
data modeling strategy.
QTL mapping
QTL mapping analysis focuses on finding statistical associations
between genomic loci (e.g. DNA sequence variants such as SNPs)
and quantitative variation in phenotypic traits. In the simplest case, a
statistical test is applied to every genetic marker (e.g. SNP) and
individual trait (e.g. body weight) assessed in a population sample.
In this test, the hypothesis under testing is whether the sequence
variant is affecting the trait, for instance whether the presence of a
specific allele at a given genomic locus is associated with increased
body weight in the population. QTL analysis can be carried out for
any kind of measurable phenotypic trait, including cellular-level or
tissue-level phenotypes. This gives rise to several types of QTL
depending on the phenotypic trait under scrutiny that is associated
with the genomic loci: eQTL refers to the association between a
locus and gene expression levels, metabolite QTL (mQTL) refers to
the association between a locus and metabolite levels, protein QTL
(pQTL) refers to the association between a locus and protein levels,
methylation QTL (methQTL) refers to the association between a
locus and DNA methylation levels, histone QTL (histoneQTL)
refers to the association between a locus and histone modification
Biological network 
(‘omics’ data)
DNA
Sequence variation
Phenotypic effect 
(disease)
Dysregulated genes
Key
Fig. 1. Systemsgenetics overview.Systems genetics aims to identify genetic
variant(s) associated with biological networks that are dysregulated in disease
to ultimately pinpoint ‘master genetic regulators’ (i.e. the primary drivers) of
disease-associated processes.
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Fig. 2. Graph displaying the number of journal research
articles obtained when querying PubMed for integrative
genomics and systems genetics publications. The results are
broken down by year and species. PubMed was queried on the
14/07/2016. From the results, the publication type “Journal
Article” was selected (references with the publication type
“Review” were discarded). When the PubMed entries for the
papers matching the queries did not include information about
the model organism, this was added to the entry by manual
curation of the paper. In addition, the results of the queries were
also manually curated in order to remove review articles
incorrectly annotated in the “Journal Article” category.
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levels, microRNAQTL (miQTL) refers to the association between a
locus and microRNA levels, and splicing QTL (sQTL) refers to the
association between a locus and changes in relative abundance of
transcript isoforms or presence of specific exons in transcripts. The
resolution of QTL mapping is heavily dependent on the genetic
crosses and number of informative genetic markers involved; often,
QTLmapping identifies only large genomic regions associated with
phenotypic traits in which several candidate genes could be equally
implicated. Additional fine mapping strategies, for example using
congenic mapping (Denmark et al., 2008), haplotype analysis and
direct sequencing of candidate genes, are usually required to
pinpoint the gene and locate the single nucleotide variant
underlying the trait of interest.
Historically, eQTLs have been one of the first types of QTL
identified for cellular-level phenotypes (Brem et al., 2002) and are
now commonly used in integrative genomics and systems genetics
studies. Since the first eQTL studies in the early 2000s – conducted
in yeast – different terminologies have been introduced to classify
eQTLs, including cis- and trans-acting eQTLs (Jansen and Nap,
2001) or local and distal eQTLs (Albert and Kruglyak, 2015). Thus,
eQTLs can be classified as cis-acting when the expression of the
gene maps to the gene itself; often, such variants act in an allele-
specific manner [the expression of the copy of the gene located in
the homologous chromosome is not affected by the genetic variant
(Albert and Kruglyak, 2015)]. In the case of trans-acting eQTLs, the
expression of the gene maps to other genomic locations (Jansen and
Nap, 2001). Trans-regulated eQTL genes can arise as the result of
different regulatory mechanisms of expression, including genetic
variants located at regulatory regions (e.g. an enhancer) or variants
that affect the function of a transcription factor (Zhu et al., 2008).
Numerous studies have identified distinctive features of cis- and
trans-eQTLs; for instance, cis-eQTLs often exert stronger effects on
gene expression than trans-eQTLs, and trans-eQTLs appear to be
more tissue-specific than cis-eQTLs (Box 1) (Petretto et al., 2006;
Breitling et al., 2008; Fairfax et al., 2012). eQTL mapping has
shown to be very valuable to annotate the functional context within
which the many genetic variants identified by genome-wide
mapping approaches operate. Thus, the integration of eQTLs and
GWAS data can be informative to uncover molecular pathways in
disease (Nica and Dermitzakis, 2013).
Gene regulatory network and pathway analysis
Systems genetics is centered on the identification of biological
networks (typically gene networks) and pathways involved in
disease. The analysis of gene regulatory networks represents a key
step of the systems genetics strategy, as it allows one to uncover
genetic and cellular interactions associated with a particular
pathological state: information that is not attainable by traditional
single-gene mapping strategies (i.e. GWAS, WES and WGS).
Generally speaking, a gene regulatory network consists of genes,
which are represented by nodes in the network, and their functional
relationships, represented by edges connecting the nodes. There are
several techniques for gene regulatory network inference and
analysis (reviewed in Rotival and Petretto, 2014). A type of
network commonly considered in systems genetics studies is the
gene co-expression network, where genes (nodes) are linked by
undirected edges representing the inferred functional relationship
between the connected genes in a given biological context (e.g. a
particular tissue or developmental stage) (Box 1). Genes that are
co-regulated and belong to the same regulatory network are likely to
be detected as being co-expressed in the tissue or cell typewhere they
operate (Mackay, 2014). These co-expressed genes can uncover
the presence of a specific biological process (Martínez-Micaelo et al.,
2016), which might be dysregulated in disease (e.g. inflammatory
response revealed by co-expression of pro-inflammatory genes).
Beyond the identification of known biological process, co-
expression network analysis can be used to infer and refine the
molecular function of geneswith poor or unknown annotation. Using
the ‘guilty by association’ principle, the co-expression of an
uncharacterized gene with other genes of known function can help
in defining the function of the former. For instance, gene co-
expression analysis in the human heart allowedMcDermott-Roe and
colleagues to infer a previously unknown function for the enzyme
endonuclease G in fundamental mitochondrial processes occurring
in cardiac hypertrophy (McDermott-Roe et al., 2011). Gene
regulatory networks can also be analyzed (and reconstructed)
across different cell types or tissues and across multiple conditions
(e.g. between cases and controls in human disease studies), which
allows the detection of co-expressed genes, also called gene
modules, that elicit differential (or common) activation of
molecular processes (Tesson et al., 2010; Xiao et al., 2014).
The identification of a gene regulatory network is typically a first
step in a systems genetics study. Once gene networks have been
inferred in a given system, a wide range of approaches can be
applied to annotate the function of the network and to assess
enrichments for specific pathways, disease-susceptibility variants
and infer common regulatory mechanisms. For instance, one can (i)
identify specific biological processes represented in the networks
(e.g. by Gene Ontology functional enrichment analysis of the genes
forming the network) (Box 1), (ii) associate the networks with
disease susceptibility, e.g. by testing for enrichment of disease-
susceptibility variants (e.g. SNPs uncovered by GWAS) that map to
gene sequences in the network, and (iii) examine whether the genes
in the network have common regulatory mechanisms, for example
by testing for enrichment of transcription factor binding sites within
the promoter of the genes in the network (Johnson et al., 2015b). In
addition to using genetic susceptibility data such as GWAS-inferred
SNPs, gene networks can be associated with disease by
summarizing the variability of the network [e.g. by principal
component (PC) analysis; Box 1] and then correlating the major
PCs with the trait or disease (Langfelder and Horvath, 2008). This
strategy originated from the genome-wide correlation analysis of
individual cellular-level phenotypes (e.g. mRNAs, proteins,
metabolites) and whole-body quantitative phenotypes (e.g. body
mass index). The approach is based on the assumption that
‘intermediate’ cellular-level phenotypes can be associated with
variation in whole-body traits linked to disease (Passador-Gurgel
et al., 2007). Although it has proven to be a valuable strategy to
uncover molecular phenotypes associated with specific traits – for
example, the expression of certain genes has been shown to
correlate with variation in cardiac mass (Petretto et al., 2008) –
additional functional analyses are still required to validate causal
relationships (Mackay et al., 2009).
As in the case of eQTL mapping, gene networks can be linked to
the genome to find genetic variants responsible for the co-regulation
of the genes in the network – so-called ‘master genetic regulators’
(Box 1). Dissecting the genetic regulation of gene networks inferred
in a target tissue can uncover genetic control points of processes that
are deregulated in the context of disease, which might then be used
to design new drugs for therapeutic interventions. Gene networks
can be linked to the genome by individual eQTL mapping of the
genes in the network, which can point to a common regulatory locus
in the genome (Kang et al., 2014). It is also feasible to map the
variability of the whole network to the genome, and thereby define a
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‘network-QTL’. To this aim, one can summarize the gene network
profile into a single variable through a ‘variable reduction’
technique (e.g. by using the PCs of the network) and then map
the network profile using eQTL-based approaches (Johnson et al.,
2015a). Alternatively, the expression profiles of all network genes
can be jointly mapped to the genome, which can boost the power to
detect the network-QTLs [e.g. by multivariate Bayesian modeling
(Bottolo et al., 2011)]. More recent algorithmic developments also
allow networks reconstructed from multiple datasets to be jointly
mapped to the genome to identify network-QTLs across multiple
conditions (Lewin et al., 2016).
The value of the rat in studies of complex disease
In comparison to other well-characterized model organisms (such as
zebrafish or Drosophila), the genetic and phenotypic features of
rodents more closely resemble those of humans. The rat is a
mammalian species with a long-established history in biomedical
research, leading to its detailed phenotypic characterization.
Although the mouse has been the primary model of choice for
immunological phenotyping and gene-targeting studies (Jacob and
Kwitek, 2002), the rat is arguably the best model for the study of
cardiovascular and metabolic diseases (among other diseases; see
Aitman et al., 2016) because it facilitates a more accurate analysis of
clinical and cellular phenotypes in the cardiovascular system
(Gauguier, 2016). For instance, traditional QTL mapping has been
extremely successful in the rat: 109 QTLs have been mapped in the
rat for ‘heart’ traits (compared to 29 in mouse and 14 in human) and
453 QTLs have been mapped in the rat for ‘blood pressure’ traits
(compared to 40 in mouse and 77 in human) [source: Rat Genome
Database (RGD), http://rgd.mcw.edu, accessed on 02/07/16]. This
success in QTL detection for cardiovascular traits in the rat is likely
due to the fact that cardiovascular physiology is easier to monitor in
the rat than in mice. This can be explained by the bigger size of rats,
which, for instance, facilitates blood pressure monitoring via
implantable radio telemetry or performing surgical procedures in
the heart. In addition, cardiovascular physiology data in the rat has
been collected to an extent that is not yet replicated in the mouse
(Iannaccone and Jacob, 2009).
A wealth of physiological and pharmacological data has been
collected throughout the years in the rat (Jacob and Kwitek, 2002;
Shimoyama et al., 2015). Several genes and disease-associated
pathways identified in the rat have been found to be conserved in
humans and have enhanced our understanding of the genetic
contributions to human diseases (some relevant examples are
presented in Tables 1 and 2). The rat offers a source of biological
material from organs and primary cells that cannot be easily
accessed in humans (Gauguier, 2016), therefore providing a direct
means to investigate genes, pathways and multiple layers of
functional regulation of disease. Particularly advantageous for
systems genetics studies, orthogonal ‘omics’ datasets can be easily
collected from the same rat model and across different systems
(e.g. different tissue types), effectively enabling systems-level
investigations of disease in this model organism.
More recently, transgenic technologies have also been developed
for application in the rat (i.e. nuclear cloning, lentiviral-mediated
transgenesis, gene knockdown by RNA interference) (Jacob, 2010),
and even the latest genetic technologies are ready to use. These
include genome-editing technologies such as zinc-finger nucleases
(Geurts et al., 2009; Cui et al., 2011), transcription activator-like
effector nucleases (TALENs) (Mashimo et al., 2013; Ponce de León
et al., 2014) and clustered regularly-interspaced short palindromic
repeats (CRISPR)/Cas (Mashimo, 2014; Yoshimi et al., 2014)
(Box 1). The recent availability of this wide range of genetic
technologies bridges the gap between the rat model and other
commonly used mammalian model organisms, notably the mouse
(Aitman et al., 2008).
One of the key advantages of the rat model is the availability of
specialized inbred strains and large panels for genetic mapping; so
far, more than 500 inbred rat strains have been developed to model
different human diseases (Aitman et al., 2008). The availability of
rat genetic panels enables the mapping of cellular-level and whole-
body phenotypes to the genome. Towards this goal, F2 crosses and
panels of recombinant inbred (RI) strains have also been created. In
particular, RI strains provide a valuable and cumulative source of
data for genomic studies and can be fully characterized for genetic
polymorphisms (Jirout et al., 2003). Among the genetic panels that
have been developed for genetic research, the B×H/H×B rat RI
strains [population generated by an original cross between the
Brown Norway (BN) and the spontaneously hypertensive rat (SHR)
(Pravenec et al., 1989)] has been the most extensively used genetic
tool in systems genetics studies.
Since the publication of the draft sequence of the rat genome
(Gibbs et al., 2004), further efforts have been made to improve the
genomic resources available to the rat community (Atanur et al.,
2013). Nowadays, it is feasible to systematically generate a
wealth of phenotypic data (including cellular-level phenotypes) in
the rat that can be integrated with available physiological,
pharmacological and genomic information, to provide insight
into human disease (Shimoyama et al., 2016). On the basis of
these advantageous features and resources, the rat has been the
most widely used model organism for integrative genomics and
systems genetics studies of complex disease, as highlighted
below.
Landmark integrative genomics studies in the rat
This section aims to provide an overview of the main integrative
genomics studies conducted in the rat, in which ‘omics’ data have
been linked to the genome. A streamlined summary of studies is
reported in Table 1 and the implemented approaches are displayed
in Fig. 3.
Linking the transcriptome to the genome: single- and multiple-tissue
eQTL studies
Hubner et al. (2005) carried out the first multi-tissue and large-scale
integrative genomics study in the rat model system. In this study, the
authors assessed expression profiles in fat and kidney tissues in the
B×H/H×B panel of rat RI strains (Table 1). They first investigated
genes that are differentially expressed between the parental
progenitor strains (BN and SHR) in both tissues, and then carried
out genome-wide eQTL mapping, which identified thousands of
cis- and trans-regulated genes in the rat. They provided a list of
common and tissue-specific eQTLs and uncovered a preponderance
of trans-acting eQTLs among the tissue-specific eQTLs, an
observation that was further reinforced by subsequent studies
across seven tissues (Petretto et al., 2006). In addition, Hubner and
colleagues identified the regulatory genetic variants underlying the
observed transcript differences for the most statistically significant
cis-acting eQTL genes, and analyzed the colocalization of eQTLs
with whole-body pathophysiological QTLs previously mapped in
SHR. To obtain candidate genes for the regulation of human
hypertension, they focused on eQTLs that colocalize with blood
pressure-related QTLs in the rat (retrieved from the RGD). Using a
comparative genomics analysis with humans (Box 1), i.e. by
comparing the rat eQTLs with the human loci previously identified
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as human blood pressure-associated QTLs, the authors provided
new insights into the contribution of genetic variants regulating
gene expression in relevant target tissues to the molecular basis of
human hypertension. The study also emphasized the potential of the
B×H/H×B RI strains panel for the study of the genetics of any
pathophysiological phenotype that segregates in this rat population
(Hubner et al., 2005). Since the publication of this study, many other
eQTL mapping investigations followed, with the overall aim to link
the transcriptome to the genome in the rat model system.
An elegant example of integrative genomics applied to study
neurobehavioral traits in the rat is the work performed by Tabakoff
et al. (2009) (Table 1). In this study, the authors analyzed brain gene
expression in the B×H/H×B panel of rat RI strains and measured
alcohol consumption (a whole-body phenotype) to identify
candidate genes that predispose to increased alcohol intake. They
carried out correlation analysis between brain gene-expression
levels and alcohol consumption, QTL analysis of alcohol
consumption, and eQTL analysis in the rat brain. By integrating
all results, the authors were able to identify genes that correlate with
alcohol consumption and are also cis- and trans-regulated by the
genomic variants located within the implicated QTL regions, thus
pinpointing key genes underlying this whole-body trait in rats. The
results were translated to humans by analyzing data from two human
populations (Tabakoff et al., 2009). Follow-up studies provided
additional functional validation supporting the role of the
GABAergic system in alcohol consumption and other ethanol-
related behaviors (Cruz et al., 2011; Saba et al., 2011). Another
single-tissue eQTL study involved analysis of adrenal gland
expression data in the B×H/H×B panel of rat RI strains, in order
to identify sequence variations that influence catecholamine
Table 1. Summary of studies based on integrative genomics approaches in the rat
Study design Tissue or cell type Rat strains Reference
eQTL and DE Fat and kidney B×H/H×B RI panel Hubner et al., 2005
mQTL and DE Liver and plasma1 F2 (GK×BN), parental
strains
Dumas et al., 2007
eQTL and CNV identification Adrenal, fat, heart, kidney and
skeletal muscle
B×H/H×B RI panel3 Guryev et al., 2008
QTL, eQTL and correlation analysis Brain B×H/H×B RI panel Tabakoff et al.,
2009
QTL, eQTL, correlation analysis
and DE
Adrenal B×H/H×B RI panel,
parental strains
Jirout et al., 2010
QTL, eQTL, correlation analysis
and GWAS enrichments
Liver, heart, adrenal, fat,
kidney, skeletal muscle and
aorta
B×H/H×B RI panel,
parental strains
Langley et al.,
2013
QTL and eQTL Spleen F2 (DA×PVG) Thessen Hedreul
et al., 2013
eQTL, co-expression network and
TFBS analysis
Spinal cord F2 (DA×PVG) Lindblom et al.,
2014
eQTL and histoneQTL Heart and liver B×H/H×B RI panel,
parental strains
Rintisch et al.,
2014
QTL, meth-QTL and correlation
analysis
Heart B×H/H×B RI panel,
parental strains
Johnson et al.,
2014
QTL, eQTL, co-expression network
analysis, network-QTL and DE
Liver F2 (LH×LN), parental
strains
Wang et al., 2015
eQTL, correlation analysis, DE
(using mRNA, miRNA and Ribo-
seq data)
Heart and liver2 B×H/H×B RI panel,
parental strains
Schafer et al.,
2015
QTL, co-expression network,
network-QTL, correlation analysis
and DE
Brain B×H/H×B RI panel Saba et al., 2015
Integrative genomics studies resulting in the discovery of genes for complex traits and disease phenotypes
Gene
Complex trait or
disease Study design Tissue or cell type Rat strain Reference
Cd36 Insulin resistance QTL and DE Heart SHR Aitman et al., 1999
JunD Glomerulonephritis Congenic, QTL and DE Macrophages WKY Behmoaras et al.,
2008
Ephx2 Heart failure QTL, eQTL, correlation analysis
and DE
Heart F2 SHHF×SHRSP Monti et al., 2008
Ogn Left ventricular mass QTL, eQTL, correlation analysis
and DE
Heart B×H/H×B RI panel and
parental strains
Petretto et al.,
2008
Cd36 Blood pressure eQTL and correlation analysis Kidney B×H/H×B RI panel Pravenec et al.,
2008
Cyp17a1 Hypertension QTL, eQTL, DE and differential
protein levels
Liver B×H/H×B RI panel Low et al., 2013
1Expression data were collected in liver, whereas metabolic profiling was carried out in blood plasma. 2Proteomics data were only collected in liver. 3Expression
profiles were collected in B×H/H×B recombinant inbred (RI) strains panel, copy number variant (CNV) identification was carried out in several rat inbred strains.
Description of rat strains: B×H/H×B RI panel was derived by intercrossing Brown Norway (BN) and spontaneously hypertensive rat (SHR) inbred rat strains; DA
(Dark Agouti); GK (Goto-Kakizaki); PVG (Piebald Virol Glaxo); LH (Lyon hypertensive); LN (Lyon normotensive); SHHF (spontaneously hypertensive heart
failure); SHRSP (spontaneously hypertensive stroke-prone rat); WKY (Wistar Kyoto). DE, differential expression; GWAS, genome-wide association study; TFBS,
transcription factor binding sites; QTL, quantitative trait loci; eQTL, expression QTL; mQTL, metabolite QTL; methQTL, methylation QTL.
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biosynthesis and storage (Jirout et al., 2010) (Table 1). In this study,
the authors carried out differential expression analysis between the
progenitor strains (again BN and SHR), correlation analysis
between expression levels and biochemical phenotypes, QTL
mapping of biochemical phenotypes and eQTL analysis in the
B×H/H×B RI strains. They also overlapped the results with
previously annotated QTLs, ultimately identifying primary
genetic mechanisms for the regulation of hereditary hypertension
(Jirout et al., 2010).
Another example of comparative genomics of rat eQTLs and
human loci for hypertension was provided by Langley et al.
(Table 1). Their aim was to explore the functional and regulatory
mechanisms mediating the effects of genes previously reported to
be associated with elevated blood pressure in 15 human GWAS
(Langley et al., 2013). The results of this analysis supported the
hypothesis that trans-eQTLs are conserved between rats and
humans, and that they could represent the intermediate genes that
connect GWAS SNPs with associated complex phenotypes
(Fehrmann et al., 2011; Parks et al., 2013; Albert and
Kruglyak, 2015). Moreover, Langley et al. suggested that the
study of trans-eQTLs could contribute to the identification of the
functional relevance and molecular pathways underlying the
effects of genetic susceptibility variants identified in GWAS.
Following this, similar strategies have been proposed by
Björkegren et al. (2015) to unlock the heritability and genetic
etiology of coronary artery disease using GWAS data. As a final
example, a study published by Thessen Hedreul et al. (Table 1)
involved the integration of eQTL and autoimmune
encephalomyelitis QTL analysis, using gene expression profiles
collected from spleens of an F2 population of rats. This approach
identified several candidate genes and pathways involved in the
regulation of autoimmune encephalomyelitis (Thessen Hedreul
et al., 2013). In summary, these integrative genomics studies
demonstrate how genome-wide expression analysis in
pathophysiologically relevant tissues can be integrated with
genetic variation data to identify cis- and trans-eQTLs, which
in turn can pinpoint the genetic mechanisms underlying QTLs or
GWAS loci associated with complex diseases. Beyond the
widespread contribution of common genetic variants to regulate
gene expression levels, there are other sources of inter-individual
genetic variability that can have important functional effects on
the transcriptome; these will be discussed below.
Table 2. Summary of landmark systems genetics studies in the rat (top) and other organisms (bottom)
Gene
Complex trait or
disease Study design Tissue or cell type
Rat strain (top rows)/
organism (bottom rows) Reference
Rat
Ebi2 Type 1 diabetes eQTL, co-expression network analysis,
DE, TFBS analysis and GWAS
enrichments
Kidney, fat, liver, heart,
adrenal, skeletal muscle,
aorta
B×H/H×B RI panel,
parental strains
Heinig et al.,
2010
Kcnn4 Bone mass and
inflammatory
disease
eQTL, co-expression network analysis
and DE
Macrophages F2 (WKY×LEW), parental
strains
Kang et al.,
2014
Other organisms
Asxl2 Bone mineral density QTL, eQTL and co-expression network
analysis
Bone marrow Mouse Farber et al.,
2011
KLF14 Metabolic traits eQTL, correlation, TFBS analysis and
GWAS integration
Fat Human Small et al.,
2011
SESN3 Epilepsy Co-expression network analysis,
network-QTL, DE and GWAS
enrichments
Hippocampus Human and mouse Johnson et al.,
2015a
Description of rat strains: B×H/H×B recombinant inbred (RI) panel was derived by intercrossing Brown Norway (BN) and spontaneously hypertensive rat (SHR)
inbred rat strains; WKY (Wistar Kyoto); LEW (Lewis). DE, differential expression; eQTL, expression quantitative trait loci GWAS, genome-wide association study;
TFBS, transcription factor binding sites.
Ribosome 
profiling
DNA
DNA 
methylation
DNA DNA
Histone 
marks
Gene 
networkmRNA
A Metabolites
DNA
B C D
Fig. 3. Linking genotypes to cellular-level phenotypes in the rat. (A) Many integrative genomics studies link gene expression (the transcriptome) to the
genome (DNA sequence). All the examples discussed in the main text link gene expression to SNP markers, except in Guryev et al. (2008), in which gene
expression is linked to CNVs. Studies linkingmRNA levels to the genome in a single tissue includeMonti et al. (2008), Petretto et al. (2008), Pravenec et al. (2008),
Jirout et al. (2010), Low et al. (2013) and Thessen Hedreul et al. (2013), and across different tissues include Hubner et al. (2005) and Langley et al. (2013). Gene
regulatory networks can also be linked to the genome (exemplified by Lindblom et al., 2014; Saba et al., 2015; Wang et al., 2015). (B) Metabolite levels, or the
metabolome, can also be linked to the genome (exemplified by Dumas et al., 2007). (C) Epigenetic marks, including DNA-methylation levels (exemplified by
Johnson et al., 2014) and histonemarks (exemplified by Rintisch et al., 2014), can also be linked to the genome. (D) The ribosome profile, or translatome, can also
be linked to the genome (as in Schafer et al., 2015).
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Linking the transcriptome to the genome: the role of copy number
variation
The rat has also been shown to be a valuable resource for the study
of structural variants, such as copy number variants (CNVs; Box 1),
that underlie complex physiological traits and disease. The utility of
the rat model for the identification of CNVs relevant to complex
human diseases was first demonstrated by Aitman and colleagues,
who revealed that copy number polymorphism in the FCGR3 gene
(Fcgr3 in rats) – which encodes low affinity immunoglobulin
gamma Fc region receptor III – predisposes to glomerulonephritis in
both rats and humans (Aitman et al., 2006).
A second example of a rat-based study of CNVs was provided by
Guryev et al. (2008), who provided the first large catalog of
functional CNVs in the rat (Table 1). The authors used both
computational and experimental procedures to characterize CNVs
in several widely used rat strains. They uncovered thousands of
CNVs genome-wide, and found that these were non-randomly
distributed across the rat genome; for example, they reported the
tendency for CNVs to be present adjacent to telomeres and
centromeres. Similar to the conservation of rat eQTLs with human
disease loci (Hubner et al., 2005; Langley et al., 2013), these authors
reported that many of the identified CNVs had been previously
associated with human genetic disorders. For instance, among the
113 one-to-one orthologous genes that overlapped CNV regions in
both rat and human, 80 genes were also listed in the Online
Mendelian Inheritance in Man (OMIM) database (https://omim.
org), including the transcriptional activator and repressor GLIS
family zinc finger 3 (GLIS3), in which partial gene deletions cause
neonatal diabetes and congenital hypothyroidism (Dimitri et al.,
2011). In addition, the team integrated expression data from SHR,
BN and the H×B/B×H RI strains panel in five tissues (adrenal, fat,
heart, kidney and skeletal muscle) and computed the list of genes
differentially expressed between BN and SHR for each tissue, which
showed that ∼50% of the genes located within CNV regions were
differentially expressed. In the case of the B×H/H×B RI strains
panel, they showed that CNVs that regulate gene expression were
mainly tissue-independent, and that some of the transcripts located
within 0.5 Mb of a CNV were cis-acting eQTLs in all five tissues
tested (Guryev et al., 2008). This study highlighted that, as in
humans, CNVs play a pervasive role in the regulation of gene
expression and disease in the rat. The conservation of rat and human
disease-causing CNVs suggests the possibility of detailed
functional studies in the rat model (Aitman et al., 2006), in
particular in the case of human diseases for which fresh target-tissue
samples are difficult to retrieve (e.g. heart or brain).
Linking the transcriptome to the genome: gene co-expression
network studies
Gene co-expression network analysis has also proven to be a
valuable strategy to understand the regulation of gene expression
relevant to human diseases. For instance, Lindblom et al. published
a study in 2014 (Table 1) in which they performed eQTL mapping
in data collected from spinal cord tissue of an F2 rat intercross
(Lindblom et al., 2014). The aim of this work was to better
understand the mechanisms regulating complement activation in the
central nervous system. The authors identified clusters of trans-
regulated genes that included several complement proteins of
interest. This uncovered gene co-expression networks and
functional processes involved in complement activation.
Furthermore, by carrying out enrichments of transcription factor
binding sites within the genes forming part of the trans-regulated
networks, they identified a previously unknown FOX family
transcription factor as a potential candidate for the regulation of a
trans-eQTL cluster that includes the complement protein C3 gene
(Lindblom et al., 2014). An elegant study by Saba et al. (Table 1)
used the B×H/H×B RI strains panel to build co-expression networks
in the brain and associate these to predisposition towards alcohol
consumption (Saba et al., 2015). The integration of co-expression
networks, network-QTL, correlation analysis, alcohol consumption
QTL and differential expression analysis allowed the identification
of common functional pathways relevant to this trait (Saba et al.,
2015). Another example of integrative genomics in action, provided
by Wang and colleagues, leveraged gene co-expression network
analysis to shed light on metabolic syndrome in the Lyon
hypertensive rat (Table 1). The team collected data on genotypes,
23 whole-body physiological traits and gene expression (using
RNA-seq) from the liver of rats following an F2 intercross (Wang
et al., 2015). Whole-body physiological traits QTL, eQTL and
differential expression analyses were performed and integrated
to identify genes involved in pathogenesis (by prioritizing
differentially expressed eQTL genes that were located within a
QTL for metabolic syndrome-related traits, as previously proposed
by Morrissey et al., 2011). In addition, Wang and colleagues
reconstructed gene co-expression networks, mapped these to the rat
genome and searched for colocalization of metabolic syndrome-
related QTL traits and network-QTLs, which revealed candidate
genes underlying the intricate pathogenesis of metabolic syndrome.
Among these genes, the authors identified the rat gene
RGD1562963 (an ortholog of the human gene C6Orf52) as a
putative master regulator of a trans-eQTL network associated with
body weight and blood pressure. Additional experimental validation
of the role of RGD1562963 in liver metabolism and metabolic
syndrome has been planned by the authors (Wang et al., 2015).
Linking the metabolome to the genome
Current high-resolution metabolomics technologies enable the
comprehensive metabolic phenotyping of large cohorts of animal
models and human populations, and these data can be integrated
with genetic mapping analyses. mQTL studies in genetic mapping
populations is a feasible strategy for the characterization of the
multilevel control of metabolite abundance, which contributes to
a deeper understanding of genome–phenotype relationships in
disease processes (Gauguier, 2016). A landmark study published by
Dumas et al. (Fig. 3B and Table 1) demonstrated the applicability of
exploratory spectroscopic phenotyping analysis in the rat to link
metabolite variation to the genome (Dumas et al., 2007). They used
untargeted NMR spectroscopic analysis in plasma and genotype
data to identify mQTLs from a rat cross and congenic strains models
of diabetes. In doing so, for a set of ∼150 mQTLs the authors
identified candidate metabolites that were regulated by these loci. As
mQTLs can shed light on the biomarkers associated with diabetes,
they also looked at colocalisation of mQTLs with previously
reported diabetes-linked metabolic and physiological QTLs in the
rat, thereby uncovering another level of biological complexity in this
disease (Dumas et al., 2007). Similar studies of mQTLs have been
carried out using mice, which identified genetically determined
metabolites that could be candidate biomarkers for cardiometabolic
syndrome (Cazier et al., 2012; Ghazalpour et al., 2014).
Linking epigenetic marks to the genome
Epigenetics plays an essential role in the global regulation of gene
expression and biological processes. Epigenetic marks can be linked
to the genome because they provide information with respect to
modifications of the DNA and associated proteins that is not
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captured by analysis of the primary DNA sequence alone (Rintisch
et al., 2014). Post-translational modification of histones plays an
important part in genome organization and regulation of gene
expression. Rintisch et al. carried out a study (Fig. 3C and Table 1)
in which they generated a histone modification map of the rat
genome, and assessed to what extent patterns of histone
modification are affected by DNA variation (Rintisch et al.,
2014). The histone modification map was generated using
chromatin immunoprecipitation (ChIP)-seq data of histone post-
translational modifications in heart and liver tissues of BN, SHR and
the B×H/H×B RI strains. They looked at four well-characterized
histone methylation marks: H3K4me3, H3K4me1, H4K20me1 and
H3K27me3 (in the case of the RI strains, they only looked at
H3K4me3 and H3K27me3). Furthermore, they collected gene
expression profiles and combined these with the histone ChIP-seq
data. The authors analyzed the tissue specificity of histone-
modification marks and mapped the histone marks H3K4me3
(associated with active promoters) and H3K27me3 (associated with
gene silencing) to SNPs in the rat genome to identify cis- and trans-
acting histoneQTLs. Then they investigated whether the identified
histoneQTLs were also eQTLs and found that combining histone
modification data with gene expression analysis boosted the power
of eQTL detection, which represents a novel approach for the
identification of genotype–phenotype relationships. Notably, the
authors estimated that ∼36% of genes had a genotype-dependent
effect on histonemodifications that was not due to transcription. The
results of this integrative genomics analysis provided evidence that
histoneQTLs can predict gene expression levels and that joint
analysis of histone modifications and gene expression data enhances
the prediction of eQTLs in the rat (Rintisch et al., 2014). Because
eQTLs in the rat can be used to make sense of human GWAS
associations and elucidate the functional role of variants associated
with disease susceptibility (Hubner et al., 2005; Langley et al.,
2013), defining more eQTLs in disease-relevant tissues (which are
more accessible in rats than in humans) can aid the identification of
genetic mechanisms underlying human disease.
Another integrative genomics study focused on epigenetics was
conducted by Johnson and colleagues (Fig. 3C and Table 1). In this
study, the authors performed an integrative analysis of genotypes,
phenotype and genome-wide characterization of cytosine
methylation at the single nucleotide resolution in the rat (Johnson
et al., 2014). Specifically, whole-genome bisulfite sequencing in the
heart of SHR and BN rats was performed, and cytosine methylation
levels at CpG dinucleotides were linked to pathophysiological
phenotypes measured in the same animals. They identified
differentially methylated sites in cardiac tissue between SHR
and BN rats and carried out methQTL analysis in the B×H/H×B RI
strains. This analysis revealed that most of the differentially
methylated loci were cis-regulated and that the genetic regulation
of DNA methylation in the rat heart was, for the most part,
independent of cell type. In addition, they performed an association
analysis in which they correlated variation in CpG methylation with
241 physiological quantitative traits measured across the B×H/H×B
RI strains panel. Finally, they investigated the individual genetic
variants responsible for the cis-regulatory control (including allele-
specific methylation) observed in the analysis of methQTLs. This
last analysis yielded an unexpected concordance between
differentially methylated sites in the BN/SHR parental strains
and allele-specific methylation, suggesting that CpG cytosine
methylation is mainly cis-regulated by local sequence variations.
Overall, this study illustrated that CpG methylation levels are under
genetic control, providing a framework for the study of the
molecular mechanisms underlying these processes, while also
contributing to the understanding of the interrelation between the
regulation of CpG methylation and pathophysiological cardiac
phenotypes and biomarkers in the rat (Johnson et al., 2014). For
instance, the team reported significant correlation between a locus-
specific CpG methylation change in cardiac tissue and levels of
serum chromogranin B, which is a correlate of sympathetic nervous
system overactivity and has been proposed as a biomarker for heart
failure (Røsjø et al., 2010).
Linking the translatome to the genome
Schafer et al. recently pioneered a technique that allows genome-
wide translation efficiency to be measured, and they used the
method to study the role of translational regulation in complex traits
in the rat model (Schafer et al., 2015). In their analysis, the authors
performed RNA-seq and sequencing of ribosome-protected RNA
fragments (Ribo-seq) in the heart and liver of SHR and BN inbred
rat strains (Fig. 3D and Table 1). Using these Ribo-seq data, they
were able to detect more disease-specific pathways as compared
with the results of traditional differential expression analysis based
only on RNA-seq. Integration of mass-spectrometry-based
proteomics data in the liver confirmed that, at least in this tissue,
Ribo-seq was a better proxy for estimating protein levels than RNA-
seq. Additional integration of liver and heart eQTL data in the H×B/
B×HRI strains panel revealed that∼80% of the genes with an eQTL
were also differentially translated between the two parental strains,
suggesting that translation and transcription are correlated in many
instances. However, the authors pinpointed several differentially
translated genes with no overlap with any eQTL. This shows that
Ribo-seq can identify genomic variants associated with differential
translation that are missed by RNA-seq- or microarray-based eQTL
studies. In addition, they noticed a higher density of SNPs in the 3′
UTR of genes with translational control and, by additional
integration of miRNA sequencing in the liver and heart, they
found that differentially transcribed miRNAs are enriched in the 3′
UTR of genes with differential translation. This elegant study
integrates for the first time in the rat an additional layer of regulatory
information (i.e. the translatome) with DNA sequence variation
data, proposing Ribo-seq to be considered alongside RNA-seq
analysis in future integrative studies that use this model system
(Schafer et al., 2015).
Integrative genomics studies that led to disease-gene
identification
A pioneer example of integrative genomics study in the rat that led to
the discovery of a gene underlying the regulation of complex disease
was performed by Aitman and colleagues (Aitman et al., 1999).
This work sought to identify candidate genes that underlie insulin
resistance, defective fatty acid metabolism and hypertriglyceridemia
in the SHR background (Table 1). First, the authors carried out QTL
analysis for the traits insulin-mediated glucose uptake and
catecholamine-mediated lipolysis. Second, by integrating the QTL
data with gene expression profiling, they found that platelet
glycoprotein 4 (Cd36) was located within the identified QTL
region and differentially expressed between SHR and BN rats.
Further characterization, including overexpression experiments in a
transgenic mouse, established the role of Cd36 as a regulator of
whole-body lipid homeostasis, suggesting a role in the pathogenesis
of insulin resistance syndromes (Aitman et al., 1999). Their findings
were validated in an independent transgenic rescue study, in which
transgenic expression of Cd36 in SHR contributed to improved
insulin resistance and lower levels of serum fatty acids (Pravenec
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et al., 2001). Following this, Pravenec et al. published a study in
which they used integrative genomics based on eQTL analysis in the
rat kidney to demonstrate a role for Cd36 as a major determinant of
blood pressure and risk for hypertension (Pravenec et al., 2008).
Specifically, the authors combined eQTL analysis in the kidney of
H×B/B×H RI strains with genome-wide correlation analysis
between all cis-regulated QTLs in kidney and radio-telemetry
measures of blood pressure (Table 1). Cd36 yielded the strongest
correlation with blood pressure variation. Additional experiments in
transgenic SHR and congenic strains involving renal transplantation
of kidneys with different versions of Cd36 provided supporting
evidence to the hypothesis that loss of Cd36 leads to higher blood
pressure levels (Pravenec et al., 2008).
Another rat study, from Behmoaras and colleagues (Table 1),
combined congenic, linkage and genome-wide gene expression
analyses to discover the activator protein-1 (AP-1) transcription
factor JunD as a major determinant of macrophage activity and its
association with glomerulonephritis susceptibility. Notably, this
integrative genomics study revealed conservation of JunD function
in macrophage activation between rats and humans, therefore
suggesting a new therapeutic strategy for diseases characterized by
inflammation and macrophage activation (Behmoaras et al., 2008).
Starting from an eQTL approach, a study by Monti et al.
identified bifunctional epoxide hydrolase 2 (Ephx2) as a heart
failure susceptibility gene (Monti et al., 2008) (Table 1). The
authors combined invasive hemodynamic measurements,
expression profiling and genome mapping in F2 hybrids bred
from the spontaneously hypertensive heart failure-prone and the
spontaneously hypertensive stroke-prone rats (the latter strain does
not develop heart failure). Also in this study, eQTL analysis led to
the initial identification of Ephx2 as a strong cis-regulated gene
located within a heart failure QTL in the rat. Furthermore, Ephx2
was strongly correlated with ejection fraction (a clinical measure to
characterize heart failure) and differentially expressed between the
parental strains, an observation that was also validated at the protein
level. Finally, the team showed that knockout of Ephx2 in mice
provides protection from cardiac arrhythmias and improvement of
heart failure-related clinical parameters compared to wild-type mice
(Monti et al., 2008).
A successful discovery that stemmed from genome-wide eQTL
analysis in the rat relates to the osteoglycin (Ogn) gene, which our
group identified as a major regulator of left ventricular mass (LVM)
via the transforming growth factor beta (TGFβ) signaling pathway
(Petretto et al., 2008). In this work, spearheaded by the Cook and
Petretto laboratories at Imperial College London, we integrated
eQTLs mapping in cardiac tissue with QTL analysis of LVM, by
means of genome-wide correlation analysis of cardiac gene
expression with LVM (Table 1), using the B×H/H×B RI strains.
This approach resulted in the identification of an LVM QTL region
in whichOgnwas the strongest cis-regulated eQTL gene correlating
with LVM and that was also differentially expressed between BN
and SHR parental rat strains. Additional genome-wide correlation
analysis of cardiac expression and LVM in a human cohort yielded
OGN (as well as several members of the TGFβ pathway) as the gene
most strongly associated with LVM. We also showed that an
Ogn knockout mouse model displays lower LVM in vivo, providing
compelling evidence for Ogn as a major regulator of LVM in rats,
mice and humans (Petretto et al., 2008).
A study published by Low et al. involved the integration of
transcriptome and proteome data, which led to the identification of
the steroid 17-alpha-hydroxylase/17,20 lyase (Cyp17a1) as a
candidate for blood pressure regulation (Low et al., 2013). The
authors combined RNA-seq with liquid chromatography and mass
spectrometry to analyze the transcriptome and proteome of liver
tissue in two rat strains (BN and SHR). Comparison of the
differentially expressed genes with the differential protein levels
led to the identification of Cyp17a1 as the most downregulated gene
in SHR compared to BN at both the transcript and protein level
(Table 1). Further analyses revealed that Cyp17a1 is a cis-regulated
gene, located within a blood pressure QTL, in the H×B/B×H RI
strains. The authors identified a single nucleotide variant in the
promoter of the gene as the most likely source of its variation in gene
expression. The human ortholog, CYP17A1, had previously been
found to be a top association hit in a blood pressure GWAS, further
highlighting the power of the rat system to identify genes with a
conserved role in human disease (Low et al., 2013).
Landmark systems genetics studies in the rat
In this section we present a summary of systems genetics
analyses in the rat, with a focus on those studies where both
master genetic regulators and genetic networks underlying
complex disease have been identified and translated to humans
(Table 2 and Fig. 4). Although we focus on the two main systems
genetics studies carried out so far in the rat system (Heinig et al.,
2010; Kang et al., 2014), we will also comment on related
systems genetics investigations carried out in other species
(humans in particular).
The first integrated systems genetics study was performed in the
rat and the results were translated to humans (Heinig et al., 2010)
(Fig. 4B, Table 2). In this work, integration of a transcription-factor-
driven co-expression network with network-QTL mapping
pinpointed the Epstein–Barr virus induced gene 2 (EBI2) as a
master genetic regulator of a network of antiviral expression
associated with type 1 diabetes (T1D) risk. Under the hypothesis
that loci associated with perturbation of genetic networks could be
relevant for disease risk, Heinig and colleagues carried out genome-
wide co-expression network analysis in seven tissues from the H×B/
B×HRI strains (liver, heart, adrenal, fat, kidney, skeletal muscle and
aorta). This analysis led to the discovery of a co-expression network
with an overrepresentation of genes involved in inflammatory
processes, containing several targets of the transcription factor
interferon regulatory factor 7 (Irf7). Bayesian network-QTL
mapping (Petretto et al., 2010) in the seven rat tissues revealed
that the genes in the network were controlled by a common
regulatory hotspot (Box 1) that was located at the rat Ebi2 gene
locus. The authors also used comparative genomics to translate the
findings to humans. These studies uncovered that the rat antiviral co-
expression network is conserved in human monocytes (an
observation that was replicated in two independent population
cohorts) and that the human EBI2 gene colocalizes with a T1D
susceptibility locus previously identified by GWAS but not
followed up (Wellcome Trust Case Control Consortium., 2007;
Barrett et al., 2009). The human gene network was linked to
susceptibility to disease: the authors demonstrated that the genetic
sequences of the human genes included in the co-expression
network were overrepresented for T1D GWAS susceptibility
variants (Heinig et al., 2010). The genetic control of the network
was also identified in human monocytes. However, this study
highlights the power of the rat system for mapping the genetic
control of complex regulatory networks to discrete genomic loci,
which, when analyzed in humans, can reveal new determinants of
complex disease or, as in this case, can be critical to functionally
annotate and corroborate a previously reported GWAS signal for
T1D.
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A second system genetics study in the rat provides an example of
how the characterization of clusters of trans-eQTLs can lead to the
identification of trans-acting genetic regulators of complex traits
(Fig. 4B, Table 2). In this example, Kang et al. performed genome-
wide eQTL mapping in multinucleating macrophages in the rat [in a
segregating population derived from Lewis andWistar Kyoto inbred
rat, an experimental model of glomerulonephritis (Behmoaras et al.,
2008)]. This genome-wide eQTL analysis uncovered a large cluster
of trans-eQTLs, which yielded the discovery of a gene co-
expression network enriched for genes involved in macrophage
multinucleation (termed ‘macrophage multinucleation network’).
This network-QTL (coinciding with the single trans-eQTL hotspot)
was located within the Trem (triggering receptor expressed on
myeloid cells) gene family (Kang et al., 2014). Further functional
analyses, together with siRNA-mediated knockdown of TREM2 in
both rat and human macrophages, evidenced that TREM2 was
trans-regulating the macrophage multinucleation network in both
organisms. Additionally, by using two independent murine models,
the authors found that the most strongly trans-regulated gene of the
network, Kcnn4, which encodes intermediate conductance calcium-
activated potassium channel protein 4, is implicated in the
regulation of macrophage multinucleation, bone homeostasis,
inflammatory arthritis and glomerulonephritis. These findings
provided novel insights into the molecular mechanisms of
macrophage multinucleation, uncovered new regulators of these
processes and offered novel therapeutic targets for inflammatory
disease (Kang et al., 2014). This study highlights how the
identification of trans-eQTL genes can lead to the discovery of
networks (in this case underlying macrophage multinucleation) and
genes regulating specific cellular processes with global phenotypic
effects, as shown for two inflammatory diseases.
As well as these two rat studies, it is worth mentioning other
notable and successful examples of system genetics studies
performed in other animals. For example, using mice, Farber et al.
identified Asxl2 (additional sex combs like-2) as the gene
underlying a bone mineral density (BMD) GWAS hit (Farber
et al., 2011) (Table 2). In this study, eQTL and co-expression
network analyses were carried out with data collected from a large
mouse genetic panel. The mouse results were translated and
integrated with human BMD GWAS data. Moving on to work
carried out entirely in humans, a study performed by Small et al.
(Table 2) identified Krüppel-like factor 14 (KLF14) as a trans-
acting master genetic regulator of a gene network that regulates
metabolic traits (Small et al., 2011). In this case, the genes in the
network were mapping in trans (in human fat tissue) to the KLF14
locus, which had been previously identified in GWAS studies as
being associated with type 2 diabetes and levels of high-density
lipoprotein cholesterol (Teslovich et al., 2010; Voight et al., 2010).
Another human study, performed by Johnson et al., identified the
sestrin-3 (SESN3) gene as a positive (trans-acting) master genetic
regulator of an epileptic-gene network (Table 2). The gene network
was reconstructed using genome-wide expression analysis of
surgically resected hippocampi from individuals with temporal
lobe epilepsy. The epileptic-gene network was associated with
susceptibility to epilepsy by integration with separately obtained
GWAS data. Finally, by providing experimental evidence in two
model organisms –mouse and zebrafish – the authors demonstrated
the cross-species conservation of the epileptic-gene network and the
role of SESN3 as a modulator of chemically induced seizures in vivo
(Johnson et al., 2015a). These studies demonstrate how systems
genetics can be applied to shed light on the molecular mechanisms
underlying GWAS hits as well as to annotate the function of the
many susceptibility variants identified for human disease.
Concluding remarks
The plethora of disease-predisposing gene variants identified by
GWAS, WES and WGS has not been paralleled by a similarly fast
and far-reaching characterization of the associated biological
processes and pathways. We foresee that the increased
availability of ‘omics’ data generated across many model
organisms, as well as in humans, is likely to yield a more
powerful and synergistic platform for developing cross-species
systems genetics approaches. Indeed, all successful systems
Whole-body
phenotype mRNA
Correlation 
analysis or 
di erential 
expression
QTL eQTL
A  Integrative genomics
DNA
DNA
Whole-body
phenotype
Cellular
phenotype
Whole-body
phenotype
B  Systems genetics
DNA
Trans-eQTL
network
GWAS 
analysis
Multi-tissue
trans-eQTL
network
 
Fig. 4. Integrative genomics and systems genetics strategies in the rat.
(A) Integrative genomics studies have led to the identification of disease genes,
for instance by integrating QTL data (Aitman et al., 1999; Behmoaras et al.,
2008) or eQTL data (Monti et al., 2008; Petretto et al., 2008; Pravenec et al.,
2008; Low et al., 2013) with analysis of gene expression in disease-relevant
tissues and cell types. (B) Systems genetics studies have identified master
genetic regulators of trans-eQTL networks. Left: trans-eQTL networks were
associated with cellular-level traits driving whole-body phenotypes in rodents
(i.e. bone homeostasis and inflammatory disease) (Kang et al., 2014). Right:
trans-eQTL networks identified in the rat were conserved to humans and
enriched for GWAS variants, therefore linking the networks to a whole-body
disease phenotype (i.e. type 1 diabetes) (Heinig et al., 2010) (see Table 2).
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genetics studies discussed in this Review took advantage of
genome-scale datasets available in multiple species (rats, mice,
humans, zebrafish, and others). In the near future, the increasingly
common use of emerging genomics technologies, such as
single cell sequencing (Tang et al., 2009) or chromosome
conformation capture-based techniques (Jin et al., 2013), will
provide more detailed genomic and regulatory information, which
can be similarly integrated in more advanced systems genetics
investigations. The rat, as well as other model organisms, will
continue to be highly relevant for this upcoming stream of
advanced system genetics studies of complex disease.
We believe that the attainment of several systems genetics studies
in the rat has been greatly facilitated by substantial collaborative
efforts of the rat genetics community, which for instance in Europe
has been supported bymore than 10 years of continued funding (e.g.
the STAR, EURATools and EURATRANS projects). This enabled
the rat genetics community to focus on the accumulation of
extensive ‘omics’ and physiological phenotype data in the same
genetic mapping populations [e.g. in the H×B/B×H recombinant
inbred strains (Pravenec et al., 1989) or in outbred rats (Rat Genome
Sequencing and Mapping Consortium et al., 2013)]. This strategic
vision relied on the added value of measuring high-resolution
phenotype data in the same system, which has been rewarding even
when pursued in relatively small genetic crosses or mapping
populations (e.g. in the 30 available H×B/B×H recombinant inbred
strains). A similarly comprehensive and high-resolution collection
of ‘omics’ and phenotypic measurements in relevant tissues and cell
types is still not feasible in large human population cohorts. This
unique wealth of ‘omics’, physiological and pharmacological data
collected in the last 100 years in the rat makes this model organism
an optimal system to apply integrative genomics and systems
genetics to boost the discovery and functional characterization of
genes and pathways for human disease.
This article is part of a special subject collection ‘Spotlight on Rat: Translational
Impact’, guest edited by Tim Aitman and Aron Geurts. See related articles in this
collection at http://dmm.biologists.org/collection/rat-disease-model.
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